Clinical Trials for Metastatic Salivary Gland Carcinoma

Find clinical trials for metastatic salivary gland carcinoma. Discover research opportunities and treatment options in your area.

4 Active Trials Found

Showing 4 trials on this page

Page 1 of 1

MC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer

NCT ID: NCT04895735

This clinical trial is studying the combination of two drugs, pemetrexed and pembrolizumab, to see how effective they are in treating patients with advanced salivary gland cancer that has either re...

Recruiting

Phase: PHASE2 Type: interventional Locations: Scottsdale, Arizona, United States, Jacksonville, Florida, United States +2 more

Testing the Anti-Cancer Drug Darolutamide in Patients With Testosterone-driven Salivary Gland Cancers

NCT ID: NCT05669664

This clinical trial is studying the effectiveness of two medications, darolutamide and leuprolide acetate, in treating patients with certain types of salivary gland cancers that are driven by male ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Oklahoma City, Oklahoma, United States, New York, New York, United States +29 more

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

NCT ID: NCT04704661

The DASH Trial is a clinical study exploring the safety and effectiveness of two anti-cancer drugs, DS-8201a and AZD6738, for patients with various types of advanced solid tumors that express the H...

Recruiting

Phase: PHASE1 Type: interventional Locations: Bethesda, Maryland, United States, Saint Louis, Missouri, United States +22 more

Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

NCT ID: NCT05408845

This clinical trial is exploring a new treatment for patients with a specific type of salivary gland cancer that tests positive for the HER2 protein. The treatment being studied is called ado-trast...

Recruiting

Phase: PHASE2 Type: interventional Locations: Milwaukee, Wisconsin, United States, Charleston, South Carolina, United States +124 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions